Back

Esperovax receives USPTO allowance for yeast-based therapeutic protein patent

Verifying
  • Esperovax received a USPTO Notice of Allowance for a yeast-based therapeutic protein application.
  • Application 18/038,673 covers producing therapeutic proteins inside the body using engineered yeast.
  • Esperovax expects issuance after completing the USPTO's requirements.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.